摘要 |
The invention provides peptides that are useful for treating or preventing, or preventing the progression of a disorder associated with aberrant TDF polypeptide or TDFRP compound target molecule expression or activity, for example a kidney disease or disorder, in a subject. The invention also provides methods of treating a subject having a disorder associated with aberrant TDF polypeptide or TDFRP compound target molecule expression or activity, such as a kidney disease or disorder, comprising administering to the subject an effective amount of the peptides of the invention. |
申请人 |
THRASOS INNOVATION, INC.;KECK, PETER, C.;BEY, PHILIPPE;LEGER, ROGER;DROGARIS, PAUL |
发明人 |
KECK, PETER, C.;BEY, PHILIPPE;LEGER, ROGER;DROGARIS, PAUL |